Raymond James & Associates’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
$28M Buy
441,590
+133,144
+43% +$8.43M 0.02% 654
2024
Q2
$16.4M Buy
308,446
+63,206
+26% +$3.35M 0.01% 874
2024
Q1
$20.1M Buy
245,240
+107,657
+78% +$8.83M 0.01% 774
2023
Q4
$2.56M Buy
137,583
+68,921
+100% +$1.28M ﹤0.01% 1945
2023
Q3
$760K Buy
68,662
+150
+0.2% +$1.66K ﹤0.01% 2625
2023
Q2
$1.11M Buy
68,512
+22,541
+49% +$365K ﹤0.01% 2391
2023
Q1
$765K Sell
45,971
-47,896
-51% -$797K ﹤0.01% 2620
2022
Q4
$882K Sell
93,867
-10,861
-10% -$102K ﹤0.01% 2501
2022
Q3
$285K Sell
104,728
-8,281
-7% -$22.5K ﹤0.01% 3196
2022
Q2
$327K Sell
113,009
-10,742
-9% -$31.1K ﹤0.01% 3165
2022
Q1
$371K Sell
123,751
-13,464
-10% -$40.4K ﹤0.01% 3241
2021
Q4
$631K Sell
137,215
-114,121
-45% -$525K ﹤0.01% 2916
2021
Q3
$1.58M Sell
251,336
-8,085
-3% -$50.8K ﹤0.01% 2261
2021
Q2
$1.55M Sell
259,421
-142,309
-35% -$852K ﹤0.01% 2279
2021
Q1
$2.54M Buy
401,730
+108,349
+37% +$685K ﹤0.01% 1850
2020
Q4
$1.65M Sell
293,381
-86,935
-23% -$490K ﹤0.01% 2010
2020
Q3
$2.21M Buy
380,316
+272
+0.1% +$1.58K ﹤0.01% 1694
2020
Q2
$2.74M Buy
380,044
+120,986
+47% +$872K ﹤0.01% 1535
2020
Q1
$1.21M Sell
259,058
-2,714
-1% -$12.7K ﹤0.01% 1860
2019
Q4
$2.1M Sell
261,772
-71,220
-21% -$571K ﹤0.01% 1796
2019
Q3
$2.29M Sell
332,992
-81
-0% -$557 ﹤0.01% 1693
2019
Q2
$2.77M Buy
333,073
+3,347
+1% +$27.8K ﹤0.01% 1598
2019
Q1
$3.28M Buy
329,726
+164,457
+100% +$1.63M 0.01% 1449
2018
Q4
$1.26M Buy
165,269
+22,122
+15% +$169K ﹤0.01% 1953
2018
Q3
$2.49M Buy
+143,147
New +$2.49M ﹤0.01% 1683